89 related articles for article (PubMed ID: 16014328)
1. Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation.
Locker M; Bitard J; Collet C; Poliard A; Mutel V; Launay JM; Kellermann O
Cell Signal; 2006 May; 18(5):628-39. PubMed ID: 16014328
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C.
Baudry A; Bitard J; Mouillet-Richard S; Locker M; Poliard A; Launay JM; Kellermann O
J Biol Chem; 2010 Aug; 285(34):26066-73. PubMed ID: 20573958
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid.
Palomba L; Bianchi M; Persichini T; Magnani M; Colasanti M; Cantoni O
Free Radic Biol Med; 2004 Feb; 36(3):319-29. PubMed ID: 15036351
[TBL] [Abstract][Full Text] [Related]
4. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Berg KA; Maayani S; Clarke WP
Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
[TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid release from NIH 3T3 cells by group-I phospholipase A2: involvement of a receptor-mediated mechanism.
Xing M; Miele L; Mukherjee AB
J Cell Physiol; 1995 Dec; 165(3):566-75. PubMed ID: 7593236
[TBL] [Abstract][Full Text] [Related]
7. Control of bioamine metabolism by 5-HT2B and alpha 1D autoreceptors through reactive oxygen species and tumor necrosis factor-alpha signaling in neuronal cells.
Schneider B; Pietri M; Mouillet-Richard S; Ermonval M; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2006 Dec; 1091():123-41. PubMed ID: 17341609
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism.
Tournois C; Mutel V; Manivet P; Launay JM; Kellermann O
J Biol Chem; 1998 Jul; 273(28):17498-503. PubMed ID: 9651340
[TBL] [Abstract][Full Text] [Related]
9. Opposing regulation of cell proliferation by retinoic acid and the serotonin2B receptor in the mouse frontonasal mass.
Bhasin N; LaMantia AS; Lauder JM
Anat Embryol (Berl); 2004 May; 208(2):135-43. PubMed ID: 14991402
[TBL] [Abstract][Full Text] [Related]
10. Expression of serotonin receptors in bone.
Westbroek I; van der Plas A; de Rooij KE; Klein-Nulend J; Nijweide PJ
J Biol Chem; 2001 Aug; 276(31):28961-8. PubMed ID: 11387323
[TBL] [Abstract][Full Text] [Related]
11. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor.
Manivet P; Mouillet-Richard S; Callebert J; Nebigil CG; Maroteaux L; Hosoda S; Kellermann O; Launay JM
J Biol Chem; 2000 Mar; 275(13):9324-31. PubMed ID: 10734074
[TBL] [Abstract][Full Text] [Related]
12. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L
Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130
[TBL] [Abstract][Full Text] [Related]
13. Augmented prostaglandin E2 generation resulting from increased activities of cytosolic and secretory phospholipase A2 and induction of cyclooxygenase-2 in interleukin-1 beta-stimulated rat calvarial cells during the mineralizing phase.
Higashi S; Ohishi H; Kudo I
Inflamm Res; 2000 Mar; 49(3):102-11. PubMed ID: 10807497
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells.
Launay JM; Schneider B; Loric S; Da Prada M; Kellermann O
FASEB J; 2006 Sep; 20(11):1843-54. PubMed ID: 16940156
[TBL] [Abstract][Full Text] [Related]
15. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach.
Antoniotti S; Fiorio Pla A; Pregnolato S; Mottola A; Lovisolo D; Munaron L
J Cell Physiol; 2003 Dec; 197(3):370-8. PubMed ID: 14566966
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2-dependent pathway.
Yoshida K; Shinohara H; Haneji T; Nagata T
Oral Dis; 2007 Jan; 13(1):32-9. PubMed ID: 17241427
[TBL] [Abstract][Full Text] [Related]
17. Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes.
Sampey AV; Hutchinson P; Morand EF
Mediators Inflamm; 2000; 9(3-4):125-32. PubMed ID: 11132768
[TBL] [Abstract][Full Text] [Related]
18. The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells.
Kifor O; Diaz R; Butters R; Brown EM
J Bone Miner Res; 1997 May; 12(5):715-25. PubMed ID: 9144337
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2 is involved in muscarinic receptor-mediated sAPPalpha release independently of cyclooxygenase or lypoxygenase activity in SH-SY5Y cells.
Cho HW; Kim JH; Choi S; Kim HJ
Neurosci Lett; 2006 Apr; 397(3):214-8. PubMed ID: 16406345
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2.
Bosetti F; Langenbach R; Weerasinghe GR
J Neurochem; 2004 Dec; 91(6):1389-97. PubMed ID: 15584915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]